May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?

Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/41262

Título :	May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
Autor:	Adamowicz, Jan Juszczak, Kajetan Drewa, Tomasz
Palavras-chave:	COVID-19 5-alpha-reductase inhibitors
Publicador:	Elsevier
Data da publicação:	Jul-2020
Referência:	ADAMOWICZ, J.; JUSZCZAK, K.; DREWA, T. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications? Medical Hypotheses, [S.l.], v. 140, July 2020.
Abstract:	COVID-19 pandemic is a major challenge for global and national healthcare providers. Number of new cases is continuously increasing with an emerging trend showing worse prognosis in males in comparison to females. Based on this observation, our proposed hypothesis is that 5-alpha-reductase inhibitors, that are commonly used for BPH treatment, may be one of the factors contributing to poorer prognosis in males.
URI:	https://www.sciencedirect.com/science/article/abs/pii/S0306987720305909 http://repositorio.ufla.br/jspui/handle/1/41262
Idioma:	en_US
Aparece nas coleções:	FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:

Não existem arquivos associados a este item.